236 related articles for article (PubMed ID: 24416423)
21. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
22. FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors.
Cheng JC; Chang HM; Qiu X; Fang L; Leung PC
Biochem Biophys Res Commun; 2014 Jan; 443(2):537-42. PubMed ID: 24332943
[TBL] [Abstract][Full Text] [Related]
23. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
[TBL] [Abstract][Full Text] [Related]
24. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines.
Jamieson S; Fuller PJ
Horm Cancer; 2013 Oct; 4(5):277-92. PubMed ID: 23674259
[TBL] [Abstract][Full Text] [Related]
26. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
[TBL] [Abstract][Full Text] [Related]
27. SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element.
Tran S; Lamba P; Wang Y; Bernard DJ
Mol Endocrinol; 2011 Jul; 25(7):1170-83. PubMed ID: 21622537
[TBL] [Abstract][Full Text] [Related]
28. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
Kyrönlahti A; Rämö M; Tamminen M; Unkila-Kallio L; Butzow R; Leminen A; Nemer M; Rahman N; Huhtaniemi I; Heikinheimo M; Anttonen M
Endocrinology; 2008 Nov; 149(11):5635-42. PubMed ID: 18653721
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
[TBL] [Abstract][Full Text] [Related]
30. FOXO1 Negates the Cooperative Action of FOXL2
Belli M; Secchi C; Stupack D; Shimasaki S
J Endocr Soc; 2019 Nov; 3(11):2064-2081. PubMed ID: 31701078
[TBL] [Abstract][Full Text] [Related]
31. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
Rosario R; Blenkiron C; Shelling AN
Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087
[TBL] [Abstract][Full Text] [Related]
34. FOXL2 posttranslational modifications mediated by GSK3β determine the growth of granulosa cell tumours.
Kim JH; Kim YH; Kim HM; Park HO; Ha NC; Kim TH; Park M; Lee K; Bae J
Nat Commun; 2014; 5():2936. PubMed ID: 24390485
[TBL] [Abstract][Full Text] [Related]
35. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL
Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of CDH13, DKK3 and FOXL2 promoters and the expression of EZH2 in ovary granulosa cell tumors.
Xu Y; Li X; Wang H; Xie P; Yan X; Bai Y; Zhang T
Mol Med Rep; 2016 Sep; 14(3):2739-45. PubMed ID: 27431680
[TBL] [Abstract][Full Text] [Related]
38. FoxL2 and Smad3 coordinately regulate follistatin gene transcription.
Blount AL; Schmidt K; Justice NJ; Vale WW; Fischer WH; Bilezikjian LM
J Biol Chem; 2009 Mar; 284(12):7631-45. PubMed ID: 19106105
[TBL] [Abstract][Full Text] [Related]
39. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract][Full Text] [Related]
40. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
Rosario R; Cohen PA; Shelling AN
Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
